Edward M. MD Kaye - Mar 15, 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CEO, Director
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
4
Date filed
3/17/2023, 04:33 PM
Previous filing
Jan 4, 2023
Next filing
Sep 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (Right to Buy) Award $0 +213K $0.00 213K Mar 15, 2023 Common Stock 213K $9.15 Direct F1
transaction STOK Restricted Stock Unit (RSU) Award $0 +142K $0.00 142K Mar 15, 2023 Common Stock 142K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3 The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date.